Mark Joseph Kastantin

Title: Innovator Mark Joseph Kastantin: Pioneering Pharmaceutical Formulations

Introduction: Mark Joseph Kastantin, an innovative inventor based in Bend, Oregon, has made significant contributions to the pharmaceutical field. With two patents to his name, Kastantin is recognized for his work on unique formulations that offer potential therapeutic benefits.

Latest Patents: Mark Kastantin's most recent patents focus on the formulations of 4-methyl-5-(pyrazin-2-yl)-3H-1,2-dithiole-3-thione. The first patent covers the compositions that include quantities of oltipraz crystals, detailing methods of creating these compounds and their applications in treating patients. The second patent expands on this concept by introducing taste-modified formulations, which further enhance the usability of these compositions. Both patents demonstrate innovative approaches in the formulation of pharmaceutical products.

Career Highlights: Currently, Mark is associated with St IP Holding AG, a company involved in intellectual property management and technological advancements. His experience and expertise have allowed him to play a crucial role within the organization, helping to drive innovation in drug development.

Collaborations: In his professional journey, Mark has collaborated with notable colleagues, including Anthony Chris Garland and Barbara-Jean Anne Bormann-Kennedy. These partnerships highlight his ability to work alongside other talented individuals in the pursuit of advancing pharmaceutical science.

Conclusion: Mark Joseph Kastantin is a prominent inventor whose work focuses on innovative pharmaceutical formulations. With a proven track record of patents and collaborations, he continues to contribute to advancements in the healthcare industry, showcasing the importance of innovation in improving patient outcomes.